Crossref
Favorable outcomes in triple-negative breast cancer managed without neoadjuvant therapy
European Journal of Cancer · 2026-03 · 237 · 116483
DOI: 10.1016/j.ejca.2026.116483 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-03. Verfasst von B. Mollavelioglu und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mollavelioglu, B., Emiroglu, B., Bagbudar, S., Emiroglu, S., Tukenmez, M., Cabioglu, N., & Muslumanoglu, M. (2026). Favorable outcomes in triple-negative breast cancer managed without neoadjuvant therapy. European Journal of Cancer, 237, 116483. https://doi.org/10.1016/j.ejca.2026.116483
Vancouver
Mollavelioglu B, Emiroglu B, Bagbudar S, Emiroglu S, Tukenmez M, Cabioglu N, et al. Favorable outcomes in triple-negative breast cancer managed without neoadjuvant therapy. European Journal of Cancer. 2026;237:116483. doi:10.1016/j.ejca.2026.116483
BibTeX
@article{Mollavelioglu2026,
author = {Mollavelioglu, B. and Emiroglu, B. and Bagbudar, S. and Emiroglu, S. and Tukenmez, M. and Cabioglu, N. and Muslumanoglu, M.},
title = {Favorable outcomes in triple-negative breast cancer managed without neoadjuvant therapy},
journal = {European Journal of Cancer},
year = {2026},
volume = {237},
pages = {116483},
doi = {10.1016/j.ejca.2026.116483}
}
EUVIMED